Devi SenGupta

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection
    Devi SenGupta
    UCSF Division of Experimental Medicine, Building 3, Room 603, San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110, USA
    J Virol 85:6977-85. 2011
  2. pmc Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells
    Henri Alexandre Michaud
    Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94110 Equipe Immunité et Cancer, Institut de Recherche en Cancérologie de Montpellier, 34298 Montpellier Cedex 5, France
    J Immunol 193:1544-8. 2014
  3. pmc Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects
    Ravi Tandon
    Division of Experimental Medicine, University of California San Francisco, Department of Medicine, 1001 Potrero Avenue, San Francisco, CA 94110, USA
    J Virol 85:11526-31. 2011
  4. pmc Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection
    Henri Alexandre Michaud
    Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, USA
    Retrovirology 11:10. 2014

Collaborators

Detail Information

Publications4

  1. pmc Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection
    Devi SenGupta
    UCSF Division of Experimental Medicine, Building 3, Room 603, San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110, USA
    J Virol 85:6977-85. 2011
    ..These findings suggest a possible role for anti-HERV immunity in the control of chronic HIV-1 infection and provide support for a larger effort to design an HIV-1 vaccine that targets conserved antigens such as HERV...
  2. pmc Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells
    Henri Alexandre Michaud
    Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94110 Equipe Immunité et Cancer, Institut de Recherche en Cancérologie de Montpellier, 34298 Montpellier Cedex 5, France
    J Immunol 193:1544-8. 2014
    ..Thus, Abs directed against epitopes other than HIV-1 proteins may have a role in eliminating HIV-1-infected cells and could be targeted in novel vaccine approaches or immunotherapeutic modalities. ..
  3. pmc Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects
    Ravi Tandon
    Division of Experimental Medicine, University of California San Francisco, Department of Medicine, 1001 Potrero Avenue, San Francisco, CA 94110, USA
    J Virol 85:11526-31. 2011
    ..These data indicate that HERV-specific T cells may participate in controlling HIV-1 replication and that certain highly conserved HERV-derived proteins may serve as promising therapeutic vaccine targets in HIV-1-infected children...
  4. pmc Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection
    Henri Alexandre Michaud
    Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, USA
    Retrovirology 11:10. 2014
    ..We also mapped the specificity of the humoral response to HERV-K (HML-2) Envelope protein in HIV-1 infected subjects at different stages of disease, and correlated the response with plasma viral load...